Last reviewed · How we verify

NCT06620549: SKILLS-2

Feasibility of Nurse-performed Gastric Ultrasound After Surgery

Recruiting now Last updated 1 October 2024
What this trial tests

trial testing gastric ultrasonograppy in Point-of-care-ultrasound in 135 participants. Currently enrolling.

Timeline
22 April 2024
Primary endpoint
16 November 2024
24 December 2024

Quick facts

Lead sponsorRadboud University Medical Center
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment135
Start date22 April 2024
Primary completion16 November 2024
Estimated completion24 December 2024
Sites2 locations across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Radboud University Medical Center

Who can join

18 and older, any sex, with Point-of-care-ultrasound or Gastric Ultrasonography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gastric ultrasound is a quick and non-invasive tool to evaluate gastric content. Emptying of gastric content can be affected after abdominal surgery leading to the inability of tolerating oral foods. Gastric content can be assessed by gastric ultrasound and nurses were recently trained to do so in healthy volunteers; however, feasibility of nurse-performed gastric ultrasound after major abdominal surgery is not investigated yet. This study aims to investigate the feasibility of nurse-performed gastric point-of-care ultrasound after major gastro-intestinal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Point-of-care-ultrasound

Currently open trials in the same condition.

Other Radboud University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06620549.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing